Trending News
OTC: RHHBY 1.26%
FDA Approves Genentech's Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer
NASDAQ: XFOR 3.04%
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
OTC: HSTXF 6.17%
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
NYSE: ZETA 1.85%
HackerOne Report Highlights Challenges of 'Exposure Debt': NYSE Content Update
NASDAQ: ARQT 5.49%
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
NYSE: USAS 2.95%
Silver Is Headed for a Sixth Straight Year of Supply Shortfall
NYSE: RHHBY 3.04%
NYSE: XFOR 3.04%
NYSE: HSTXF 3.04%
NYSE: ZETA 3.04%
NYSE: ARQT 3.04%
